Paul Webb
Assoc. Research Biochemist, UCSF Diabetes Center
George Perentesis, Pharm.D, FCP
Vice President of Research & Development, Sucampo Pharmaceuticals
David Robbins, M.D.
Director - Medical - Endocrine Research, Eli Lilly & Co.
David G. Maggs, M.D.
Amylin Pharmaceuticals
Philip Larsen, M.D., Ph.D.
CEO, Rheoscience
Don Zappe
Novartis
Scott Braunstein
J.P. Morgan
Emil Kakkis
BioMarin Pharmaceutical, Inc.
Barry Kenny
Paradigm Therapeutics Ltd.
Jeff Machak
Senior Principal, Strategic Alliances, Pfizer Inc.
William Mann
Executive Director, Business Development, Rejuvenon Corp.
Linda M. Pullan, Ph.D.
Vice President, Business Development, Kosan Biosciences Inc.
David Jones
Director of Business Development, Bayhill Therapeutics, Inc.
Blake M. Paterson, M.D.
CEO, Alba Therapeutics
Kyle W. Gano, Ph.D.
Senior Manager, Business Development, Neurocrine Biosciences, Inc.
Reid Leonard
External Scientific Affairs, Merck & Co.
Chris Bunker
Cell Signaling Technology, Inc.
Carl Spana, Ph.D.
President and CEO, Palatin Technologies
Mark Tepper, Ph.D.
President, CytRx Laboratories
Thomas J. Colatsky, Ph.D.
Vice President, Healthcare Research, Icoria
Tim Duffy
VP, Marketing & Business Development, Nastech Pharmaceutical Co.
Stefan Schaefer
Cardiovascular Diseases, Aventis Pharmaceuticals
Mustufa Noor, M.D.
Director, HIV & Metabolism Pharmaceutical Research Inst., Bristol-Myers Squibb
Marc Rendell, M.D.
Creighton Diabetes Center
Peter McNamara, Ph.D.
Head, Metabolic Diseases, Phenomix Corporation
George Yancopoulos, M.D., Ph.D.
President of Labs & Chief Scientific Officer, Regeneron Pharmaceuticals, Inc.
Joel Ray, M.D.
Obstetrical Medicine and General Internal Medicine, St. Michael’s Hospital, University of Toronto
David V. Erbe, Ph.D.
Pricipal Research Scientist II, Cardiovascular and Metabolic Diseases,
Wyeth Research
Seymour Alpert
Professor Emeritus of Physics, University of New Mexico
Tung M. Fong, Ph.D.
Director of Obesity & Metabolic Disorders, Merck Research Laboratories
Stephen James, Ph.D.
Director,Integrated Pharmacology,Biovitrum
S. Ram Pillarisetti, Ph.D.
Vice President of Research, Reddy US Therapeutics
|